Manuscripts
Showing 1530 manuscripts.
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings
Citation
Caitlin M. Dugdale, Ogochukwu Ufio, Christopher Alba, Sallie R. Permar, Lynda Stranix-Chibanda, Coleen K. Cunningham, Genevieve G. Fouda, Landon Myer, Milton C. Weinstein, Valériane Leroy, Elizabeth J. McFarland, Kenneth A. Freedberg, Andrea L. Ciaranello. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings. Lancet. 2023. PMID: 36604316
Year
Journal
Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy
Citation
Ann J Melvin, Meredith Warshaw, Alexandra Compagnucci, Yacine Saidi, Linda Harrison, Anna Turkova, Gareth Tudor-Williams, PENPACT-1 (PENTA 9/PACTG 390/ANRS 103) Study Team. Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy. Journal of Pediatric Infectious Disease Society. 2017. 6: e109-e115. PMID: 28903520
Year
Journal
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation
Citation
Dwight E Yin, Meredith G Warshaw, William C Miller, Hannah Castro, Susan A Fiscus, Lynda M Harper, Linda J Harrison, Nigel J Klein, Joanna Lewis, Ann J Melvin, Gareth Tudor-Williams, Ross E McKinney Jr, PENPACT-1 (PENTA 9/PACTG 390) Study Team. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation. 2014. PMID: 25266426
Year
Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial
Citation
Debika Bhattacharya, Camlin Tierney, Kevin Butler, Flavia Matovu Kiweewa, Dhayendre Moodley, Vani Govender, Tichaona Vhembo, Neaka Mohtashemi, Hannah Ship, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Mary Glenn Fowler, Marion G Peters, Judith S. Currier. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Clinical Infectious Diseases. 2023. PMID: 37535953
Year
Journal
Study
Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
Citation
Kristina M. Brooks, Jennifer J. Kiser, Lauren Ziemba, Shawn Ward, Yasha Rani, Tim R. Cressey, Gaerolwe R. Masheto, Haseena Cassim, Jaime G. Deville, Ponego L. Ponatshego, Faeezah Patel, Linda Aurpibul, Shaun L. Barnabas, Iris Mustich, Anne Coletti, Barbara Heckman, Chelsea Krotje, Mark Lojacono, Dwight E. Yin, Ellen Townley, Jack Moye, Sai Majji, Edward P. Acosta, Kevin Ryan, Hardik Chandasana, Cynthia H. Brothers, Ann M. Buchanan, Helena Rabie, Patricia M. Flynn, IMPAACT 2019 Study Team. Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023. 10: E506-E517. PMID: 37541705
Year
Journal
Study
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Deborah Persaud, Yvonne Bryson, Bryan S Nelson, Camlin Tierney, Mark F Cotton, Anne Coletti, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Christina Reding, Mary N Carrington, Sai Majji, Dwight E Yin, Patrick Jean-Philippe, Ellen G Chadwick. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2023. 23: 2352-3018. PMID: 38061376
Year
Journal
Study
Micronutrients and Nutritional Status among Children living with HIV with and without Severe Acute Malnutrition: IMPAACT P1092
Citation
Mutsa Bwakura-Dangarembizi, Lauren Ziemba, Camlin Tierney, Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello, Renee Browning, John Moye, Tichaona Vhembo, James S. Ngocho, Macpherson Mallewa, Lameck Chinula, Philippa Musoke, Maxensia Owor, IMPAACT P1092 Team. Micronutrients and Nutritional Status among Children living with HIV with and without Severe Acute Malnutrition: IMPAACT P1092. BMC Nutrition. PMID: 37919816Journal
Study
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial
Citation
Amita Gupta, Priya Singh, Lisa Aaron, Grace Montepiedra, Tsungai Chipato, Lynda Stranix-Chibanda, Vongai Chanaiwa, Tichaona Vhembo, Mercy Mutambanengwe, Gaerolwe Masheto, Mpho Raesi, Sarah Bradford, Amanda Golner, Diane Costello, Vandana Kulkarni, Aisa Shayo, Enid Kabugho, Patrick Jean–Phillippe, Nahida Chakhtoura, Timothy R. Sterling, Gerhard Theron, Adriana Weinberg, IMPAACT P1078 TB APPRISE Study Team. Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. Lancet Child and Adolescent Health. 2023. 7: 708-717. PMID: 37634517